Hot Life Science Investor Mandate 2: Western Europe-Based Pharmaceutical Company Seeking Aesthetic Technologies

29 Oct

A private specialty pharmaceutical company is headquartered in Germany with offices all around the world. The firm’s venture fund focuses on early stage companies, and positions itself to be a strategic corporate partner to develop and support innovative technologies to commercialization in areas for growth opportunity – specifically focused solely in the aesthetics and cosmetics space. The firm currently manages a $30 million (€25 million) fund, and typically makes $1-$5 million investments. The firm is seeking 4-5 investments in early-stage companies, start-ups including spinout companies from academia. The firm is geographically agnostic, and is open to investments from all over the world.

The firm focuses only on aesthetics with an anti-aging focus, including skin rejuvenation and body shaping and modification. The firm is open to all therapeutics, medical devices, and healthcare IT, as long as the technology serves an unmet need/gap in the aesthetic marketplace. The firm has historically invested in injectables, toxins, topicals, cosmetics, and devices. The firm typically looks at seed to early stage companies, and specifically focuses on pre-clinical to clinical stages and pre-concept to concept devices.

As a strategic corporate partner, the firm hopes to bring its own expertise and internal resources to the table. As not only an investor, but also as a strategic partner, the firm anticipates being able to offer advice, support, and consultation for the early-stage company to leverage its global comprehensive network of experts within the firm. The firm offers R&D, clinical, regulatory through to commercial, sales and marketing expertise. The firm believes that providing these services and support to a start-up company is a substantial value-add and will help partnered companies grow and develop with the ability to tap into the firm’s expertise. Thus, the firm will help fill the management team with their global network of internal resources, along with providing all the aforementioned services.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: